Capital-FORCE has moved two Investor’s Business Daily-linked equity strategies onto its newly organized ETF platform, formally adding the CapForce IBD 50 ETF and the CapForce IBD Breakout Opportunities ETF as the first flagship products in a rules-based lineup aimed at advisors and growth-oriented investors.
The Los Angeles-based firm said on April 29 that the CapForce IBD 50 ETF, trading under ticker FFTY, and the CapForce IBD Breakout Opportunities ETF, trading under ticker BOUT, had successfully transitioned to the Capital-FORCE ETF platform. The funds retain their existing ticker symbols, while their names and CUSIPs now reflect the new CapForce branding.
The shift follows Capital-FORCE’s acquisition of the two legacy strategies from Innovator’s ETF lineup and places them at the center of a platform built around systematic equity selection, dynamic portfolio management and the long-running IBD methodology. The firm said the funds are intended to become foundational building blocks for a broader set of evidence-based ETFs designed to navigate changing market cycles with transparent rules rather than discretionary stock picking.
FFTY is designed to provide exposure to the IBD 50 Index, a strategy focused on U.S. large- and mid-cap companies displaying strong earnings and price strength. BOUT seeks to track the IBD Breakout Stocks Index, which targets U.S. companies showing measurable breakout characteristics, including accelerating earnings growth, relative price strength and liquidity thresholds.
The transaction is modest in scale compared with the largest ETF launches of the year, but it is significant for the product-development pattern it represents. Rather than introducing entirely new funds, Capital-FORCE is attempting to reposition existing ETFs with established tickers, known index methodologies and a sharper distribution narrative. In a crowded ETF market, that approach can preserve continuity for shareholders while giving the issuer a chance to reset messaging, operations and advisor outreach.
Capital-FORCE Chief Executive Mark MacArthur described the transition as a logical next step because it combines historically grounded research, rules-based stock selection and the ETF structure increasingly used by investors. The firm said it expects renewed marketing, distribution and operational focus to support future asset growth and broader adoption of the strategies.
The funds sit in a segment of the ETF industry that blends index discipline with growth and momentum exposure. FFTY and BOUT are not conventional broad-market products tracking benchmarks such as the S&P 500 or Russell 1000. Their methodologies are narrower and more selective, seeking to identify companies that meet quantitative and fundamental screens tied to leadership, earnings strength and price action.
That positioning may appeal to advisors looking for differentiated equity sleeves, but it also gives the funds a more tactical profile. Concentrated growth and momentum strategies can outperform during strong leadership cycles, especially when market breadth narrows around companies with accelerating earnings and durable relative strength. They can also underperform sharply when momentum reverses, valuation discipline returns or investors rotate into defensive, dividend-oriented or value sectors.

For Capital-FORCE, the key strategic question is whether the IBD brand and methodology can gain new relevance within a modern ETF distribution environment. Investor’s Business Daily has long been associated with growth-stock research, earnings momentum screens and market leadership analysis. By licensing that framework into transparent ETFs, Capital-FORCE is seeking to convert a research-driven stock-selection discipline into rules-based portfolios that can be traded intraday and held through standard brokerage and advisory platforms.
BOUT’s investment proposition is explicitly tied to breakout investing. The fund seeks exposure to companies that may be moving beyond prior resistance levels and entering periods of sustained price growth. Its index methodology uses objective criteria and regular rebalancing, aiming to reduce subjective decision-making while keeping the portfolio aligned with current technical and fundamental inputs.
FFTY, meanwhile, is positioned as a concentrated growth-equity strategy built around the IBD 50 Index. The fund seeks exposure to companies with strong earnings and price performance characteristics, a profile that can overlap with market leadership themes in technology, industrial innovation, consumer growth, health care and other sectors depending on the index’s current composition.
The relaunch also comes as ETF issuers face a more selective environment for smaller and specialized funds. Investors have continued to allocate heavily to low-cost core index products, active fixed-income ETFs, options-based income funds and high-profile thematic strategies. Smaller equity ETFs without clear distribution support have often struggled to gather assets, leading some issuers to merge, reorganize or close products that lack scale.
Capital-FORCE is taking the opposite route from closure by making FFTY and BOUT the base of a focused platform. The firm said it intends to use the IBD methodology across a complementary product set, emphasizing dynamic portfolio management, clear factor exposure and the accessibility of the ETF vehicle. That suggests the company may use FFTY and BOUT as proof points before expanding into adjacent rules-based strategies.
The ETF structure remains central to the pitch. ETFs offer daily transparency, exchange trading, tax efficiency mechanisms and relatively simple access for advisors and self-directed investors. For rules-based growth strategies, the wrapper can be especially useful because investors can monitor holdings, rebalance allocations and use the funds as tactical positions without opening separately managed accounts or relying on opaque model portfolios.
Still, the funds carry the usual risks associated with equity ETFs and more specific risks tied to concentrated growth exposure. Capital-FORCE’s release said investors should review objectives, risks, charges and expenses before investing and noted that no investment strategy is guaranteed to succeed or meet its objectives. The funds are distributed by Foreside Fund Services.

The transition also underscores a broader ETF industry theme: the line between passive indexing and active strategy continues to blur. FFTY and BOUT track indexes, but the indexes themselves are built from proprietary screens and periodic rebalancing rules. That makes them different from traditional market-cap-weighted benchmarks, even though the funds remain index-tracking ETFs.
For advisors, the practical question is portfolio role. FFTY may be used as a high-conviction growth allocation for investors seeking exposure to companies with earnings and price leadership. BOUT may be considered a more tactical breakout-oriented sleeve for investors comfortable with momentum-driven selection. Neither fund is likely to function as a full replacement for diversified U.S. equity beta; instead, each may be evaluated as a satellite allocation within a broader equity portfolio.
The timing of the transition may also help Capital-FORCE frame the funds around market leadership rather than broad optimism. U.S. equities have remained sensitive to interest-rate expectations, earnings revisions and volatility in high-growth sectors. In that backdrop, rules-based strategies that systematically screen for strength can attract investors who want exposure to leadership trends but prefer a predefined methodology over discretionary security selection.
However, momentum and breakout strategies are heavily dependent on market regime. In periods when leadership is persistent and earnings growth is rewarded, such strategies may capture concentrated winners. In choppy markets, false breakouts, rapid factor reversals and narrow liquidity can weigh on performance. That makes rebalancing discipline and index construction important parts of the investment case.
The platform’s future growth will likely depend on three variables: whether Capital-FORCE can raise awareness among financial advisors, whether the IBD methodology continues to resonate with growth investors, and whether the funds can deliver differentiated performance after fees relative to broader growth benchmarks and competing factor ETFs.
The April 29 announcement gives Capital-FORCE a clearer identity in the ETF market. Rather than entering with generic beta funds, the firm is anchoring its brand to IBD-linked, rules-based growth strategies with existing tickers and a recognizable methodology. That may give the issuer a more defined lane, but it also places execution pressure on distribution, education and performance consistency.
For the ETF industry, the move is another example of product platforms being rebuilt around acquired or reorganized strategies. As the market matures, issuers are increasingly competing not only on fees but on methodology, narrative and use case. Capital-FORCE’s wager is that FFTY and BOUT can be more than legacy products: they can serve as the foundation for a specialized rules-based growth franchise.